Health TrialsbyHealthPanel

Relapsed or Refractory Non-Hodgkin's Lymphoma

1

Review clinical trials related to Relapsed or Refractory Non-Hodgkin's Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

The study is a Phase I/II, single-arm, open-label clinical trial, and its primary objective of phase I and phase II is to evaluate the safety and efficacy of U16 Injection in the treatment of relapsed or refractory NHL,respectively.

Participants needed: 100
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUpdated: Oct 2, 2026Locations: 3
Eligibility criteria

Trial participants voluntarily sign the informed consent form and have good comp... [+12]

Concurrent other malignancies, except for malignancies with disease-free surviva... [+18]

Read more